Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation
about
Control of RANKL gene expressionActivated human T cells express alternative mRNA transcripts encoding a secreted form of RANKLOsteoprotegerin in bone metastases: mathematical solution to the puzzleReceptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases.Nutraceutical fatty acids as biochemical and molecular modulators of skeletal biology.Bone destruction in arthritis.Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysisThe effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis.Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma.Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.Osteolysis and cancer.RANK ligand is a prerequisite for cancer-associated osteolytic lesions.TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblastsIdentification of RANKL in osteolytic lesions of the facial skeleton.The role of TNF-α and TNF superfamily members in the pathogenesis of calcific aortic valvular disease.Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor–κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton
P2860
Q24619669-CB0D562B-BDAD-4D77-980A-3489171A6A51Q24632345-F5A4FDCB-45B3-45FF-AEEC-F8336E7D4BE8Q27329714-E735824D-6464-4495-9D12-C3D2E063D4BEQ34086847-26061FB2-2971-4472-8F22-2F0291376BB3Q34402915-518B7DD3-9C80-4488-B384-6906F747E5C1Q34963176-1760B6C6-C286-47AC-BFDB-60FDD39580C9Q35843398-1AB32AA9-1BBB-4152-8459-5CE3865AD1D0Q36376105-11D6E569-6189-4410-B93F-EB4E8940215DQ36480992-7D4B8D4F-2DEC-41B0-BA2F-F4673B8CEF40Q37865591-F67758E1-CBFD-4312-B98F-B9821DCEE512Q39946634-C7FEF0D7-405F-4D64-BFE4-5B0286EE21F8Q39946675-C9B335B6-8864-4AB0-A9C3-85214949EDE6Q40703245-CD321ED1-CAF7-4006-ACFE-D478DC55EAC1Q42532851-6757739F-4C5D-40A7-BC48-1E0A2012223CQ47880647-28C070A3-B2DC-4AAE-8793-B90E288A9732Q54487255-9F3CEE3C-0C73-4F5F-9E05-CE3122F4E6E5Q57904787-533BCDA4-D3AE-4DEA-9195-5E9A02C4D54F
P2860
Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cancer cells responsible for h ...... t induces osteoclast formation
@ast
Cancer cells responsible for h ...... t induces osteoclast formation
@en
Cancer cells responsible for h ...... t induces osteoclast formation
@en-gb
Cancer cells responsible for h ...... t induces osteoclast formation
@nl
type
label
Cancer cells responsible for h ...... t induces osteoclast formation
@ast
Cancer cells responsible for h ...... t induces osteoclast formation
@en
Cancer cells responsible for h ...... t induces osteoclast formation
@en-gb
Cancer cells responsible for h ...... t induces osteoclast formation
@nl
prefLabel
Cancer cells responsible for h ...... t induces osteoclast formation
@ast
Cancer cells responsible for h ...... t induces osteoclast formation
@en
Cancer cells responsible for h ...... t induces osteoclast formation
@en-gb
Cancer cells responsible for h ...... t induces osteoclast formation
@nl
P2093
P3181
P356
P1476
Cancer cells responsible for h ...... t induces osteoclast formation
@en
P2093
P3181
P356
10.1006/BBRC.2000.2314
P407
P577
2000-03-16T00:00:00Z